{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:39:23Z","timestamp":1763059163107,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.idnow.2024.104952","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T16:39:13Z","timestamp":1719679153000},"page":"104952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccination of teenagers in France over a 10-year period (2012\u20132021)"],"prefix":"10.1016","volume":"54","author":[{"given":"J.","family":"Gaudelus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-3557","authenticated-orcid":false,"given":"J.P.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Denigot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0454-4592","authenticated-orcid":false,"given":"L.","family":"Mediouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.idnow.2024.104952_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2020.12.021","article-title":"Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data","volume":"39","author":"Marchal","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.idnow.2024.104952_b0010","unstructured":"Sant\u00e9 Publique France. Donn\u00e9es de couverture vaccinale dipht\u00e9rie-t\u00e9tanos, poliomy\u00e9lite, coqueluche par groupe d'\u00e2ge. 202. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-de-couverture-vaccinale-diphterie-tetanos-poliomyelite-coqueluche-par-groupe-d-age. Accessed 07-12-2022."},{"key":"10.1016\/j.idnow.2024.104952_b0015","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Vaccination des femmes enceintes contre la coqueluche. Questions \u2013 R\u00e9ponses pour les professionnels de sant\u00e9. 2022. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/qr_professionnels_coqueluche_28062022.pdf. Accessed 12-12-2022."},{"key":"10.1016\/j.idnow.2024.104952_b0020","unstructured":"Institut Pasteur. Whooping cough (pertussis) - The situation in France: surveillance and vaccinations. https:\/\/www.pasteur.fr\/en\/medical-center\/disease-sheets\/whooping-cough. Accessed 05-09-2023."},{"key":"10.1016\/j.idnow.2024.104952_b0025","unstructured":"Institut national de la sant\u00e9 et de la recherche m\u00e9dicale (INSERM). H\u00e9patite B - Une infection potentiellement grave contre laquelle un vaccin offre une protection efficace. 2017. https:\/\/www.inserm.fr\/dossier\/hepatite-b\/. Accessed 13-10-2023."},{"key":"10.1016\/j.idnow.2024.104952_b0030","first-page":"57","article-title":"Vivre avec une h\u00e9patite B : Une enqu\u00eate des \u00c9tats g\u00e9n\u00e9raux de l\u2019h\u00e9patite B en France m\u00e9tropolitaine et d\u2019outre-mer \/ Living with hepatitis B: A survey by the General Estates of hepatitis B in mainland and overseas France","volume":"3\u20134","author":"Hadey","year":"2022","journal-title":"Bulletin\u00e9pidemiologique hebdomadaire"},{"key":"10.1016\/j.idnow.2024.104952_b0035","first-page":"38","article-title":"En route vers l\u2019\u00e9limination des h\u00e9patites virales B et C en France \/ Towards the elimination of viral hepatitis B and C in France","volume":"3\u20134","author":"Dabis","year":"2022","journal-title":"Bulletin\u00e9pidemiologique hebdomadaire"},{"issue":"5","key":"10.1016\/j.idnow.2024.104952_b0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/microorganisms10050907","article-title":"Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic","volume":"10","author":"Deghmane","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.idnow.2024.104952_b0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40121-021-00546-z","article-title":"Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM)","volume":"11","author":"Shen","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.idnow.2024.104952_b0050","unstructured":"Vaccination Info Service. M\u00e9ningites et septic\u00e9mies \u00e0 m\u00e9ningocoques. 2022. https:\/\/vaccination-info-service.fr\/Les-maladies-et-leurs-vaccins\/Meningites-et-septicemies-a-meningocoques. Accessed 30-11-2022."},{"key":"10.1016\/j.idnow.2024.104952_b0055","unstructured":"Koeck JL. D\u00e9but d'une \u00e9pid\u00e9mie de rougeole en France : le point sur les recommandations vaccinales. 2018. https:\/\/www.mesvaccins.net\/web\/news\/12100-debut-d-une-epidemie-de-rougeole-en-france-le-point-sur-les-recommandations-vaccinales. Accessed 03-10-2023."},{"key":"10.1016\/j.idnow.2024.104952_b0060","unstructured":"Vaccination Info Service. Rougeole. 2022. https:\/\/vaccination-info-service.fr\/Les-maladies-et-leurs-vaccins\/Rougeole. Accessed 06-12-2022."},{"key":"10.1016\/j.idnow.2024.104952_b0065","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). La HAS recommande de vacciner aussi les gar\u00e7ons contre les papillomavirus. 2019. https:\/\/www.has-sante.fr\/jcms\/p_3135747\/fr\/la-has-recommande-de-vacciner-aussi-les-garcons-contre-les-papillomavirus. Accessed 18-11-2022."},{"issue":"11","key":"10.1016\/j.idnow.2024.104952_b0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14760584.2020.1858057","article-title":"The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018\u20132019)","volume":"19","author":"Bonanni","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.idnow.2024.104952_b0075","doi-asserted-by":"crossref","unstructured":"Gaudelus J, Cohen R, Martinot A, Stahl JP, Lery T, Le Danvic M et al. [Vaccination of teenagers. Mission: impossible?]. Medecine et maladies infectieuses. 2013;43(2):49-51. DOI: 10.1016\/j.medmal.2013.03.006.","DOI":"10.1016\/j.medmal.2013.03.006"},{"key":"10.1016\/j.idnow.2024.104952_b0080","unstructured":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9. Programme national d\u2019am\u00e9lioration de la politique vaccinale 2012 - 2017. 2012. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/programme_national_amelioration_politique_vaccinale.pdf. Accessed 07-12-2022."},{"issue":"2","key":"10.1016\/j.idnow.2024.104952_b0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.medmal.2020.09.027","article-title":"Evolution between 2008 and 2018 of mothers' perception regarding vaccination and infant vaccine coverage in France","volume":"51","author":"Martinot","year":"2021","journal-title":"Infectious diseases now"},{"issue":"2","key":"10.1016\/j.idnow.2024.104952_b0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.medmal.2013.01.001","article-title":"Vaccination against meningococcus C. vaccinal coverage in the French target population","volume":"43","author":"Stahl","year":"2013","journal-title":"Medecine et maladies infectieuses"},{"issue":"12","key":"10.1016\/j.idnow.2024.104952_b0095","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.arcped.2014.08.001","article-title":"\u00c9volution du taux de couverture vaccinale des enfants de moins de 7ans en France apr\u00e8s publication du calendrier vaccinal 2013","volume":"21","author":"Martinot","year":"2014","journal-title":"Arch Pediatr"},{"issue":"6","key":"10.1016\/j.idnow.2024.104952_b0100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.gofs.2022.02.081","article-title":"Should French pregnant women be vaccinated against pertussis during pregnancy?","volume":"50","author":"Hattabi","year":"2022","journal-title":"Gynecologie, obstetrique, fertilite & senologie"},{"issue":"44","key":"10.1016\/j.idnow.2024.104952_b0105","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1016\/j.vaccine.2022.09.054","article-title":"Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2\u201311 months","volume":"40","author":"Merdrignac","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.idnow.2024.104952_b0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ije\/dyl270","article-title":"Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE)","volume":"36","author":"Mallol-Mesnard","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.idnow.2024.104952_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2015.11.002","article-title":"Hepatitis B vaccination and adolescents: A lost generation","volume":"46","author":"Stahl","year":"2016","journal-title":"Medecine et maladies infectieuses"},{"key":"10.1016\/j.idnow.2024.104952_b0120","unstructured":"Sant\u00e9 Publique France. Donn\u00e9es de couverture vaccinale m\u00e9ningocoque C par groupe d'\u00e2ge. 2022. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-de-couverture-vaccinale-meningocoque-c-par-groupe-d-age. Accessed 18-11-2022."},{"issue":"2","key":"10.1016\/j.idnow.2024.104952_b0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/21645515.2018.1528831","article-title":"Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination","volume":"15","author":"Burman","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.idnow.2024.104952_b0130","unstructured":"Sant\u00e9 Publique France. Situation \u00e9pid\u00e9miologique des infections invasives \u00e0 m\u00e9ningocoque en France. Point au 31 d\u00e9cembre 2022. 2023. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/infections-invasives-a-meningocoque\/documents\/bulletin-national2\/situation-epidemiologique-des-infections-invasives-a-meningocoque-en-france.-point-au-31-decembre-2022. Accessed 05-09-2023."},{"key":"10.1016\/j.idnow.2024.104952_b0135","first-page":"199","article-title":"Transmissibilit\u00e9, contagiosit\u00e9, \u00e9viction de la cr\u00e8che, couverture vaccinale\u2026","volume":"28","author":"Cohen","year":"2008","journal-title":"M\u00e9d Enf"},{"key":"10.1016\/j.idnow.2024.104952_b0140","unstructured":"Sant\u00e9 Publique France. Synth\u00e8se des donn\u00e9es de surveillance de la rougeole du 1er janvier 2008 au 30 septembre 2019. 2019. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-prevention-vaccinale\/rougeole\/documents\/bulletin-national\/synthese-des-donnees-de-surveillance-de-la-rougeole-du-1er-janvier-2008-au-30-septembre-2019#:\u223c:text=Documentsbulletin%20national-,Synth%C3%A8se%20des%20donn%C3%A9es%20de%20surveillance%20de%20la%20rougeole%20du,2008%20au%2030%20septembre%202019&text=Du%201er%20janvier%202008%20au%2030%20septembre%202019%2C%20pr%C3%A8s%20de,pour%20la%20seule%20ann%C3%A9e%202011)). Accessed 18-11-2022."},{"key":"10.1016\/j.idnow.2024.104952_b0145","doi-asserted-by":"crossref","unstructured":"Bernadou A, Astrugue C, M\u00e9chain M, Le Galliard V, Verdun-Esquer C, Dupuy F et al. Measles outbreak linked to insufficient vaccination coverage in Nouvelle-Aquitaine Region, France, October 2017 to July 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2018;23(30):1800373. DOI: 10.2807\/1560-7917.Es.2018.23.30.1800373.","DOI":"10.2807\/1560-7917.ES.2018.23.30.1800373"},{"issue":"7","key":"10.1016\/j.idnow.2024.104952_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.medmal.2014.07.005","article-title":"HPV vaccination is still difficult to implement","volume":"44","author":"Gaudelus","year":"2014","journal-title":"Medecine et maladies infectieuses"},{"issue":"10197","key":"10.1016\/j.idnow.2024.104952_b0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.idnow.2024.104952_b0160","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/hex.13778","article-title":"Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study)","volume":"26","author":"Bocquier","year":"2023","journal-title":"Health Expect"},{"key":"10.1016\/j.idnow.2024.104952_b0165","unstructured":"Sant\u00e9 Publique France. Campagne de vaccination gratuite contre les papillomavirus dans les coll\u00e8ges. 2023. https:\/\/www.gouvernement.fr\/actualite\/campagne-de-vaccination-gratuite-contre-le-papillomavirus-dans-les-ecoles. Accessed 05-09-2023."},{"issue":"36","key":"10.1016\/j.idnow.2024.104952_b0170","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1016\/j.vaccine.2017.07.042","article-title":"Chronically ill adolescents are also incompletely vaccinated: A cross-sectional study in France","volume":"35","author":"Gras-Le Guen","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.idnow.2024.104952_b0175","unstructured":"Service-Public.fr. Les pharmaciens peuvent d\u00e9sormais vous prescrire et vous administrer vos vaccins. 2023. https:\/\/www.service-public.fr\/particuliers\/actualites\/A16732. Accessed 20-11-2023."},{"key":"10.1016\/j.idnow.2024.104952_b0180","unstructured":"Vaccination Info Service. Nourrissons et enfants (de la naissance \u00e0 13 ans). 2023. https:\/\/vaccination-info-service.fr\/La-vaccination-au-cours-de-la-vie\/Nourrissons-et-enfants-de-la-naissance-a-13-ans. Accessed 20-11-2023."},{"issue":"6","key":"10.1016\/j.idnow.2024.104952_b0185","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.vaccine.2019.11.081","article-title":"Human papillomavirus vaccination coverage, policies, and practical implementation across Europe","volume":"38","author":"Nguyen-Huu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.idnow.2024.104952_b0190","unstructured":"Sant\u00e9 publique France. Vaccination en France. Bilan de la couverture vaccinale en 2023 - Papillomavirus humain (HPV). 2024. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/documents\/bulletin-national\/vaccination-en-france.-bilan-de-la-couverture-vaccinale-en-2023. Accessed 10-05-2024."},{"issue":"3","key":"10.1016\/j.idnow.2024.104952_b0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.medmal.2016.02.002","article-title":"The impact of the web and social networks on vaccination. New challenges and opportunities offered to fight against vaccine hesitancy","volume":"46","author":"Stahl","year":"2016","journal-title":"Medecine et maladies infectieuses"},{"issue":"4S","key":"10.1016\/j.idnow.2024.104952_b0200","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.acap.2021.02.001","article-title":"Childhood and Adolescent Vaccination in Alternative Settings","volume":"21","author":"Hofstetter","year":"2021","journal-title":"Acad Pediatr"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991924001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T04:31:04Z","timestamp":1728448264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991924001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666991924001192"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104952","relation":{},"ISSN":["2666-9919"],"issn-type":[{"type":"print","value":"2666-9919"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination of teenagers in France over a 10-year period (2012\u20132021)","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.104952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104952"}}